These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 422704)

  • 1. Identification and high yield purification of insulin-like growth factors (nonsuppressible insulin-like activities and somatomedins) from human plasma by use of endogenous binding proteins.
    Ginsberg BH; Kahn CR; Roth J; Megyesi K; Baumann G
    J Clin Endocrinol Metab; 1979 Jan; 48(1):43-9. PubMed ID: 422704
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioreceptor assay of insulin-like peptides in human plasma: growth hormone dependence and correlation with sulfation activity by two bioassays.
    Guyda HJ; Corvol MT; Rappaport R; Posner BI
    J Clin Endocrinol Metab; 1979 May; 48(5):739-47. PubMed ID: 429519
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonsuppressible insulin-like activity and somatomedin C levels in normal pregnant women, in pregnant women with gestational diabetes, and in umbilical cord blood of mature and premature infants.
    Samaan NA; Vassilopoulou-Sellin R; Schultz PN; Rivera ME; Held B
    Am J Obstet Gynecol; 1985 Oct; 153(4):457-61. PubMed ID: 4050920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Somatomedins (author's transl)].
    Binoux M
    Sem Hop; 1981 May 8-15; 57(17-18):923-8. PubMed ID: 6165086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial purification and characterization of somatomedin from sheep serum.
    Hossner KL; Davis SL; Powell C; Sasser RG
    Endocrinology; 1985 Apr; 116(4):1351-6. PubMed ID: 3971919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone, somatomedin C, and nonsuppressible insulin-like activity levels compared in premature, small, average birth weight, and large infants.
    Samaan NA; Schultz PN; Johnston DA; Creasy RW; Gonik B
    Am J Obstet Gynecol; 1987 Dec; 157(6):1524-8. PubMed ID: 3425657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Competitive protein-binding assay for somatomedins and their carrier protein (author's transl)].
    Binoux M; Lassarre C; Seurin D
    Ann Endocrinol (Paris); 1980; 41(1):67-9. PubMed ID: 7396401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins.
    Van Wyk JJ; Svoboda ME; Underwood LE
    J Clin Endocrinol Metab; 1980 Jan; 50(1):206-8. PubMed ID: 7350184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of the IGF (insulin-like growth factors or somatomedins) competitive binding assay in the study of growth disorders in children (results for 124 observations) (author's transl)].
    Gourmelen M; Girard F; Binoux M
    Arch Fr Pediatr; 1980; 37 Suppl 2():XXXIII-XXXVIII. PubMed ID: 7447617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsuppressible insulin-like activity (NSILA). I. Development of a new sensitive competitive protein-binding assay for determination of serum levels.
    Schalch DS; Heinrich UE; Koch JG; Johnson CJ; Schlueter RJ
    J Clin Endocrinol Metab; 1978 Apr; 46(4):664-71. PubMed ID: 755052
    [No Abstract]   [Full Text] [Related]  

  • 11. [Somatomedins and allied peptides (author's transl)].
    Pierson M; Malaprade D; Straczek J
    Ann Pediatr (Paris); 1980 Feb; 27(2):74-86. PubMed ID: 6999960
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders.
    Zapf J; Morell B; Walter H; Laron Z; Froesch ER
    Acta Endocrinol (Copenh); 1980 Dec; 95(4):505-17. PubMed ID: 7006291
    [No Abstract]   [Full Text] [Related]  

  • 13. Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain.
    Rinderknecht E; Humbel RE
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4379-81. PubMed ID: 1069990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-suppressible insulin-like activity in Laron's syndrome.
    Kastrup KW; Zapf J
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):414-20. PubMed ID: 425784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bioassay for NSILA-S in individual serum samples and its relationship to somatotropin.
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1164-9. PubMed ID: 993319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-suppressible insulin-like serum activity (NSILA). Physiological importance and survey of the current state of research].
    Zapf J
    Fortschr Med; 1980 Jan; 98(2):66-8. PubMed ID: 7364359
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of the liver in regulating somatomedin activity: hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver.
    Schalch DS; Heinrich UE; Draznin B; Johnson CJ; Miller LL
    Endocrinology; 1979 Apr; 104(4):1143-51. PubMed ID: 436753
    [No Abstract]   [Full Text] [Related]  

  • 18. [Growth factors].
    Manso C
    Acta Med Port; 1983; 4(7-8):361-70. PubMed ID: 6356797
    [No Abstract]   [Full Text] [Related]  

  • 19. The somatomedin group of peptide growth factors.
    Van Wyk JJ; Furlanetto RW; Plet AS; D'Ercole AJ; Underwood LE
    Natl Cancer Inst Monogr; 1978 May; (48):141-7. PubMed ID: 748748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor binding protein (IGFBP-3), an inhibitor of serum growth factors other than IGF-I and -II.
    Liu L; Delbé J; Blat C; Zapf J; Harel L
    J Cell Physiol; 1992 Oct; 153(1):15-21. PubMed ID: 1381713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.